-------------------------------------------
About Dylan Eiger
Dylan Eiger is currently an MD/Ph.D. student at Duke University School of Medicine. He received his B.S. in Chemistry from Duke University in 2016 where he worked in the lab of Dr. Stephen Craig and studied polymer chemistry and material science.
He is currently finishing his Ph.D. in the lab of Dr. Sudarshan Rajagopal, a former postdoctoral fellow of Dr. Robert J. Lefkowitz. Dylan's graduate research focuses on the mechanisms underlying biased signaling at GPCRs, specifically, the role of differential receptor phosphorylation (phosphorylation barcodes) and subcellular GPCR signaling in directing functionally selective responses. He primarily studies the chemokine receptor CXCR3 as it has three naturally occurring ligands and thus serves as an endogenous example of biased agonism.
After finishing his MD/Ph.D., Dylan plans to complete his residency training in Internal Medicine and subsequently pursue fellowship training in Cardiology. He hopes to continue his research on biased agonism at GPCRs with a particular focus on the treatment of cardiovascular disease.
-------------------------------------------
We aspire to provide opportunities to connect, share, form trusting partnerships, grow, and thrive together.
Fill out the Ecosystem waitlist form today to be the first to explore our brand new and improved space!
For more details, visit our website http://www.DrGPCR.com/Ecosystem/.
-------------------------------------------
Are you a #GPCR professional?
- Register to become a Virtual Cafe speaker
http://www.drgpcr.com/virtual-cafe/
- Subscribe to our Monthly Newsletter
http://www.drgpcr.com/newsletter/
- Listen and subscribe to #DrGPCR Podcasts
http://www.drgpcr.com/podcast/
- Support #DrGPCR Ecosystem with your Donation.
http://www.drgpcr.com/sponsors/
- Reserve your spots for the next #DrGPCR Virtual Cafe
http://www.drgpcr.com/virtual-cafe/
- Watch recorded #DRGPCR Virtual Cafe presentations:
https://www.youtube.com/channel/UCJvKL3smMEEXBulKdgT_yCw
- Share your feedback with us:
